Current Ratio of ELITE PHARMACEUTICALS INC /NV/ from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Current Ratio in % history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Current Ratio for the quarter ending 31 Dec 2025 was 685%, a 112% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 685% +362% +112% 31 Dec 2025
Q3 2025 562% +281% +100% 30 Sep 2025
Q2 2025 457% +219% +92% 30 Jun 2025
Q1 2025 364% +144% +65% 31 Mar 2025
Q4 2024 323% +115% +56% 31 Dec 2024
Q3 2024 280% +24% +9.5% 30 Sep 2024
Q2 2024 237% -100% -30% 30 Jun 2024
Q1 2024 220% -192% -47% 31 Mar 2024
Q4 2023 208% -212% -50% 31 Dec 2023
Q3 2023 256% -116% -31% 30 Sep 2023
Q2 2023 337% +13% +4% 30 Jun 2023
Q1 2023 412% +149% +57% 31 Mar 2023
Q4 2022 419% +174% +71% 31 Dec 2022
Q3 2022 372% +151% +68% 30 Sep 2022
Q2 2022 324% +118% +57% 30 Jun 2022
Q1 2022 263% +78% +42% 31 Mar 2022
Q4 2021 246% +83% +51% 31 Dec 2021
Q3 2021 222% +78% +55% 30 Sep 2021
Q2 2021 206% +80% +63% 30 Jun 2021
Q1 2021 186% +70% +61% 31 Mar 2021
Q4 2020 163% +45% +39% 31 Dec 2020
Q3 2020 143% +21% +17% 30 Sep 2020
Q2 2020 126% -12% -8.9% 30 Jun 2020
Q1 2020 115% -53% -31% 31 Mar 2020
Q4 2019 117% -86% -42% 31 Dec 2019
Q3 2019 122% -131% -52% 30 Sep 2019
Q2 2019 139% -161% -54% 30 Jun 2019
Q1 2019 168% -182% -52% 31 Mar 2019
Q4 2018 204% -218% -52% 31 Dec 2018
Q3 2018 253% -209% -45% 30 Sep 2018
Q2 2018 300% -151% -33% 30 Jun 2018
Q1 2018 350% -88% -20% 31 Mar 2018
Q4 2017 421% +23% +5.8% 31 Dec 2017
Q3 2017 461% +119% +35% 30 Sep 2017
Q2 2017 451% +143% +46% 30 Jun 2017
Q1 2017 437% +140% +47% 31 Mar 2017
Q4 2016 398% +129% +48% 31 Dec 2016
Q3 2016 342% +55% +19% 30 Sep 2016
Q2 2016 308% +6.5% +2.1% 30 Jun 2016
Q1 2016 297% +57% +24% 31 Mar 2016
Q4 2015 269% +52% +24% 31 Dec 2015
Q3 2015 287% +161% +127% 30 Sep 2015
Q2 2015 301% +224% +289% 30 Jun 2015
Q1 2015 240% +187% +353% 31 Mar 2015
Q4 2014 217% +184% +556% 31 Dec 2014
Q3 2014 126% +93% +279% 30 Sep 2014
Q2 2014 77% +42% +120% 30 Jun 2014
Q1 2014 53% +19% +54% 31 Mar 2014
Q4 2013 33% +2.6% +8.5% 31 Dec 2013
Q3 2013 33% +2.3% +7.5% 30 Sep 2013
Q2 2013 35% -0.09% -0.25% 30 Jun 2013
Q1 2013 34% -8% -19% 31 Mar 2013
Q4 2012 30% -21% -40% 31 Dec 2012
Q3 2012 31% 30 Sep 2012
Q2 2012 35% 30 Jun 2012
Q1 2012 42% 31 Mar 2012
Q4 2011 51% 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.